Insulet ($PODD) announced an update on their ongoing clinical study. Study Overview: Insulet Corporation is running a new clinical study titled ...

The FDA cleared an updated algorithm for a hybrid closed-loop insulin delivery system that permits users to set a lower ...

Insulet ($PODD) announced an update on their ongoing clinical study. Study Overview Insulet’s new study, officially titled “Safety and Efficacy of ...

Omnipod is “stuck” directly on the body for three days at a time, the waterproof design means the patient can bathe or swim without any worry or disconnecting from the pump. On the other hand, a ...

If you have type 1 diabetes, you know how difficult it can feel to manage your insulin levels and track your progress over time without turning it into something that resembles a full-time job. And ...

The rate of innovation in devices for type 1 diabetes patients has accelerated rapidly in recent years, with digital technology and medical devices converging to offer new control. Most recently, ...

Insulet has announced that its Omnipod 5 Automated Insulin Delivery System has been cleared by the US Food and Drug Administration (FDA) for the indication of type 2 diabetes. The company says that ...

Omnipod is “stuck” directly on the body for three days at a time, the waterproof design means the patient can bathe or swim without any worry or disconnecting from the pump. On the other hand, a ...

Insulet could face new competition as other insulin pump companies move into tubeless devices, but CEO Jim Hollingshead said he is not concerned in the short term. The company currently is the fastest ...

Current work seeks to perfect the algorithm that would someday let the insulin pump automatically make the multitude of delivery decisions that would have been made by a healthy pancreas. Advances are ...

With a patent challenge from Medtronic ($MDT) now settled, Insulet ($PODD) is $10 million lighter but gets to keep its fleet of insulin pumps on the market. Medtronic ...